# Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD

> **NCT03055247** · PHASE2 · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 3 (estimated)

## Conditions studied

- Chronic Granulomatous Disease X-linked (X-CGD)

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Myelostim
- **DRUG:** Mozobil

## Key facts

- **NCT ID:** NCT03055247
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-11-06
- **Primary completion:** 2023-07-13
- **Final completion:** 2026-07-18
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055247, "Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03055247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*